Company profile for Telix Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Telix Pharmaceuticals Limited is a clinical-stage biotechnology company dedicated to developing a pipeline of advanced "theranostic"​ (diagnostic+therapeutic) assets for a number of unmet needs in cancer care. We are headquartered in Melbourne, Australia but our team is international. Telix is an unlisted public company. In December 2018, Telix acquired ANMI SA, a leader in the field of radiopharmaceutical development. The A...
Telix Pharmaceuticals Limited is a clinical-stage biotechnology company dedicated to developing a pipeline of advanced "theranostic"​ (diagnostic+therapeutic) assets for a number of unmet needs in cancer care. We are headquartered in Melbourne, Australia but our team is international. Telix is an unlisted public company. In December 2018, Telix acquired ANMI SA, a leader in the field of radiopharmaceutical development. The ANMI team brings a wealth of innovation and experience in the streamlined development and production of novel radiopharmaceuticals.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
Suite 401 55 Flemington Road, North Melbourne, VIC Australia, 3051
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/telix-pharmaceuticals-ltd-shareholders-with-large-losses-should-contact-robbins-llp-for-information-about-the-tlx-class-action-302627130.html

PR NEWSWIRE
28 Nov 2025

https://www.globenewswire.com/news-release/2025/11/19/3191353/0/en/ZIRCON-X-Analysis-TLX250-CDx-Impacts-Clinical-Decision-Making-for-Almost-Half-of-Patients-with-Indeterminate-Renal-Masses.html

GLOBENEWSWIRE
19 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181191/0/en/Telix-to-Participate-in-UBS-and-Jefferies-Global-Healthcare-Conferences.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/10/23/3171897/0/en/TLX250-CDx-Zircaix-Included-in-Leading-International-Guidelines-for-Renal-Imaging.html

GLOBENEWSWIRE
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/22/3171448/0/en/Telix-Doses-First-Patient-in-SOLACE-Trial-for-Metastatic-Bone-Pain.html

GLOBENEWSWIRE
22 Oct 2025

https://www.globenewswire.com/news-release/2025/10/14/3165890/0/en/Telix-Reports-US-206M-Revenue-FY-2025-Guidance-Upgraded.html

GLOBENEWSWIRE
14 Oct 2025

ABOUT THIS PAGE

Contact Telix Pharmaceuticals and get a quotation

Telix Pharmaceuticals is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find a price of Gallium Chloride bulk with DMF offered by Telix Pharmaceuticals

Find a price of Zirconium-89 bulk with DMF offered by Telix Pharmaceuticals

Find a price of [131I]-L-4-IODOPHENYLALANINE (131I-IPA) INJECTION bulk with DMF offered by Telix Pharmaceuticals

Find a price of KIT FOR THE PREPARATION OF GA-68 PSMA-11 INJECTION bulk offered by Telix Pharmaceuticals

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty